NEW YORK (GenomeWeb News) – ClinXus, a non-profit biomarker alliance based in Grand Rapids, Mich., has joined the Critical Path Institute’s Predictive Safety Testing Consortium, ClinXus said today.

 

ClinXus was formed in 2006 using $1.5 million from the Michigan 21st Century Jobs Fund and from in-kind donations from its members, which include the Van Andel Institute, Spectrum Health, Saint Mary’s Health Care, Jasper Clinical Research & Development, Grand Valley State University, and Grand Valley Medical Specialists.